文献速递肝病消化道肿瘤与早癌

评估肝细胞癌对局部区域治疗的反应:基于MRI的疗效标准与移植病理的验证比较

Evaluation of HCC response to locoregional therapy: Validation of MRI-based response criteria versus explant pathology.
PubMed 文献 · J Hepatol · 2017-08-18

本研究以移植病理为参考,评估多种MRI疗效标准预测肝细胞癌局部区域治疗后完全病理坏死的性能,纳入61例肝移植前接受局部区域治疗的患者共97个病灶。EASL/mRECIST标准和减影图像对完全病理坏死具有优秀诊断性能,其中减影图像与病理坏死程度相关性最强,作者建议用MR减影图像评估肝细胞癌对局部区域治疗的反应。

要点

  • EASL、mRECIST、坏死百分比和定性DWI均为完全病理坏死的显著预测因子(p<0.001)。
  • EASL、mRECIST和坏死百分比诊断性能相似(AUC 0.810-0.815),定性DWI较低(AUC 0.622)。
  • 减影图像与病理肿瘤坏死程度相关性最强(r=0.71-0.72,p<0.0001),作者建议用于评估疗效。

核心结论

  • EASL/mRECIST标准和减影图像对局部区域治疗后肝细胞癌的完全病理坏死具有优秀诊断性能,减影图像与病理肿瘤坏死程度相关性最佳,作者建议用MR减影图像评估肝细胞癌对局部区域治疗的反应。

研究设计与样本

  • 回顾性研究纳入61例(男/女46/15,平均年龄60岁)局部区域治疗后接受肝移植的患者,其中56例接受经动脉化疗栓塞联合射频或微波消融,5例接受90钇放射栓塞,肝移植前90天内行MRI。
  • 由三名独立阅片者评估RECIST、EASL、改良RECIST(mRECIST)、减影图像坏死百分比以及弥散加权成像(DWI)的定性(信号强度)和定量(表观弥散系数[ADC])指标,并以组织病理学回顾性评估坏死程度为参考。

主要发现

  • 共评估97个肝细胞癌病灶(平均大小2.3±1.3cm),其中28个为完全病理坏死。
  • 所有方法阅片者间一致性均优秀(ICC 0.77-0.86)。
  • EASL、mRECIST、坏死百分比和定性DWI均为完全病理坏死的显著预测因子(p<0.001),而RECIST和ADC不是。
  • EASL、mRECIST和坏死百分比诊断性能相似(AUC 0.810-0.815),定性DWI性能较低(AUC 0.622)。
  • 减影图像与病理肿瘤坏死程度相关性最强(r=0.71-0.72,p<0.0001)。

关键数值与推荐

  • EASL、mRECIST和坏死百分比预测完全病理坏死的AUC为0.810-0.815,定性DWI的AUC为0.622。
  • 减影图像与病理肿瘤坏死程度的相关系数r=0.71-0.72(p<0.0001)。
  • 所有评估方法的阅片者间一致性ICC为0.77-0.86。

临床怎么用

  • 作者建议用MR减影图像评估肝细胞癌对局部区域治疗的反应。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: This study evaluates the performance of various magnetic resonance imaging (MRI) response criteria for the prediction of complete pathologic necrosis (CPN) of hepatocellular carcinoma (HCC) post locoregional therapy (LRT) using explant pathology as a reference. METHODS: We included 61 patients (male/female 46/15; mean age 60years) who underwent liver transplantation after LRT with transarterial chemoembolization plus radiofrequency or microwave ablation (n=56), or 90Yttrium radioembolization (n=5). MRI was performed <90days before liver transplantation. Three independent readers assessed the following criteria: RECIST, EASL, modified RECIST (mRECIST), percentage of necrosis on subtraction images, and diffusion-weighted imaging (DWI), both qualitative (signal intensity) and quantitative (apparent diffusion coefficient [ADC]). The degree of necrosis was retrospectively assessed at histopathology. Intraclass correlation coefficient (ICC) and Cohen's kappa were used to assess inter-reader agreement. Logistic regression and receiver operating characteristic analyses were used to determine imaging predictors of CPN. Pearson correlation was performed between imaging criteria and pathologic degree of tumor necrosis. RESULTS: A total of 97HCCs (mean size 2.3±1.3cm) including 28 with CPN were evaluated. There was excellent inter-reader agreement (ICC 0.77-0.86, all methods). EASL, mRECIST, percentage of necrosis and qualitative DWI were all significant (p<0.001) predictors of CPN, while RECIST and ADC were not. EASL, mRECIST and percentage of necrosis performed similarly (area under the curves [AUCs] 0.810-0.815) while the performance of qualitative DWI was lower (AUC 0.622). Image subtraction demonstrated the strongest correlation (r=0.71-0.72, p<0.0001) with pathologic degree of tumor necrosis. CONCLUSIONS: EASL/mRECIST criteria and image subtraction have excellent diagnostic performance for predicting CPN in HCC treated with LRT, with image subtraction correlating best with pathologic degree of tumor necrosis. Thus, MR image subtraction is recommended for assessing HCC response to LRT. LAY SUMMARY: The assessment of hepatocellular carcinoma (HCC) tumor necrosis after locoregional therapy is essential for additional treatment planning and estimation of outcome. In this study, we assessed the performance of various magnetic resonance imaging (MRI) response criteria (RECIST, mRECIST, EASL, percentage of necrosis on subtraction images, and diffusion-weighted imaging) for the prediction of complete pathologic necrosis of HCC post locoregional therapy on liver explant. Patients who underwent liver transplantation after locoregional therapy were included in this retrospective study. All patients underwent routine liver MRI within 90days of liver transplantation. EASL/mRECIST criteria and image subtraction had excellent diagnostic performance for predicting complete pathologic necrosis in treated HCC, with image subtraction correlating best with pathologic degree of tumor necrosis.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Gordic S, Corcuera-Solano I, Stueck A, et al. Evaluation of HCC response to locoregional therapy: Validation of MRI-based response criteria versus explant pathology. J Hepatol. 2017. PMID: 28823713. doi:10.1016/j.jhep.2017.07.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。